Scienture Holdings, Inc.
Develops and commercializes specialty drugs for unmet medical needs, focusing on CNS disorders.
SCNX | US
Overview
Corporate Details
- ISIN(s):
- US89846A2078 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 20 AUSTIN BLVD., 11725 COMMACK
- Website:
- https://www.trxadehealth.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Scienture Holdings, Inc. is a pharmaceutical holding company that invests in, develops, and commercializes specialty drug products designed to address unmet medical needs. Operating through its subsidiary, Scienture LLC, the company focuses on creating innovative therapies, particularly for the treatment of central nervous system (CNS) disorders. Scienture Holdings aims to improve healthcare outcomes and provide enhanced value to patients and physicians by developing unique drug formulations and delivery systems. The company's pipeline includes the development of products such as SCN-102, an oral liquid formulation of losartan potassium.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Scienture Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Scienture Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Scienture Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
